Otsuka Pharmaceutical agrees to purchase Visterra for $430m
Japan-based Otsuka Pharmaceutical has signed a definitive merger agreement to acquire US-based biotechnology company Visterra for a cash consideration of…
Visterra
Japan-based Otsuka Pharmaceutical has signed a definitive merger agreement to acquire US-based biotechnology company Visterra for a cash consideration of…